Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | SI | P14410 | 1/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3239453 | 0.89 | TSHR (0.48) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL17190723 | 0.86 | TSHR (0.44) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL28576166 | 0.84 | L3MBTL1 (0.45) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL17190718 | 0.82 | TSHR (0.41) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL17995485 | 0.81 | TSHR (0.40) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL8686256 | 0.81 | TSHR (0.55) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL12951358 | 0.79 | TSHR (0.52) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL11062326 | 0.79 | TSHR (0.52) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL23734825 | 0.77 | SLC1A1 (0.55) | TSHRSLC1A1MGAMGAASI | |
| SCHEMBL1406208 | 0.77 | L3MBTL1 (0.50) | TSHRMGAMGAASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| US-4895872-A | TREATING HYPERACTIVE IMMUNE SYSTEMS; AUTOIMMUNE AND GRAFT/HOST DISEASES | CETUS CORPORATION (US) | 1990-01-23 | — | — | US | claimed |
| WO-1990000049-A2 | IMMUNOSUPPRESSIVE ANALOGUES AND DERIVATIVES OF SUCCINYLACETONE | CETUS CORPORATION (US) | 1990-01-11 | — | — | WO | claimed |
| US-6410805-B1 | — | — | None | — | — | US | disclosed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | disclosed |
| CN-118084638-A | Continuous production method and device of 1, 3-cyclohexanedione | 宁波天研精开技术有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-113336629-B | Preparation process of 1,3 cyclohexanedione | 上海埃农生物科技有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-113292525-B | Preparation method of delta caprolactone | 上海埃农生物科技有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-113292525-A | Preparation method of delta caprolactone | 上海埃农生物科技有限公司 | 2021-08-24 | — | — | CN | disclosed |
| US-10123978-B2 | Patch for treating dermatophytosis | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2018-11-13 | — | — | US | disclosed |
| EP-2881114-B1 | ANTI-TRICHOPHYTIC ADHESIVE PATCH | MEIJI SEIKA PHARMA CO LTD (JP) | 2018-09-05 | — | — | EP | disclosed |
| US-5453514-A | Diabetes | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1995-09-26 | — | — | US | disclosed |
| US-5252603-A | Immunosuppressive analogues and derivatives of succinylacetone | CETUS CORPORATION (US) | 1993-10-12 | — | — | US | disclosed |
| US-5216005-A | Treating autoimmune diseases, organ tissue transplants | CETUS CORPORATION (US) | 1993-06-01 | — | — | US | disclosed |
| US-5173482-A | A dioxoalkyl phosponate or a proline-modified polyoxyethylene glycol derivative; autoimmune diseases; organ transplants; immunoassay | CETUS CORPORATION (US) | 1992-12-22 | — | — | US | disclosed |
| US-5100885-A | Hypoxic tumor cells are rendered more susceptible to destruction by radiation | JOHNSON MATTHEY, INC. (US) | 1992-03-31 | — | — | US | disclosed |
| WO-1991004734-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING 4,6-TIOXOHEPTANOIC ACID OR ITS DERIVATIVES | CETUS CORPORATION (US) | 1991-04-18 | — | — | WO | disclosed |
| EP-0411935-A2 | Copper radio sensitizers | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1991-02-06 | — | — | EP | disclosed |
| US-4895872-A | TREATING HYPERACTIVE IMMUNE SYSTEMS; AUTOIMMUNE AND GRAFT/HOST DISEASES | CETUS CORPORATION (US) | 1990-01-23 | — | — | US | disclosed |
| WO-1990000049-A2 | IMMUNOSUPPRESSIVE ANALOGUES AND DERIVATIVES OF SUCCINYLACETONE | CETUS CORPORATION (US) | 1990-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10123978-B2 | Patch for treating dermatophytosis | DPM1, KRT18, LCP1 | TSHR 4300/4885SLC1A1 446/4885MGAM 3230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.